Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Litigation Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

Docket   Start Trial Date Filed 2018-08-06
Court District Court, W.D. Texas Date Terminated 2019-08-13
Cause 35:271 Patent Infringement Assigned To Earl Leroy Yeakel III
Jury Demand Plaintiff Referred To
Patents 7,828,787; 8,118,802; 8,162,915
Attorneys Alexandra D. Valenti; Brian P Murray; Cabrach J. Connor; Donald R. McPhail; Gregory D. Fernengel; Ian Scott; Jaimin Hemendra Shah; John T. Bennett; Kevin S. Kudlac; Mark G. Davis; Richard T. Ruzich; Roshan P. Shrestha; Samuel Sherry; Stephen R. Auten; Travis C. Barton
Firms Connor Kudlac Lee PLLC; Fernengel Law, LLC; Goodwin Procter LLP; Goodwin Procter LLP, NY Times Bldg.; McGinnis, Lochridge & Kilgore, LLP; Taft Stettinius & Hollister LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Fresenius Kabi USA, LLC v. Custopharm, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 37 Amended Complaint States Patent Nos. 8,118,802 (“the ‘802 patent”), 8,162,915 (“the ‘915 patent”), and 7,828,787 (“the … COUNT III FOR INFRINGEMENT OF U.S. PATENT NO. 7,828,787 66. The allegations of paragraphs… ‘787 patent”) (collectively, “the Patents-in-Suit”). This action arises out of Defendant’s filing of… BACKGROUND The Patents-in-Suit 24. The ‘802 patent, entitled “Connector for packaging…inventors assigned the ‘802 patent to Fresenius Kabi Deutschland GmbH. The ‘802 patent is listed in the Orange External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.